High incidence of invasive group A streptococcal infections in remote indigenous communities in Northwestern Ontario, Canada

Open Forum Infectious Diseases

Volumn 4, Issue 1, 2017, Pages

  Bocking, Natalie ^a   Matsumoto, Cai Lei ^a   Loewen, Kassandra ^b   Teatero, Sarah ^c   Marchand Austin, Alex ^c   Gordon, Janet ^a   Fittipaldi, Nahuel ^c,d   McGeer, Allison ^d  

^a Sioux Lookout First Nations Health Authority   (Canada)

^b Anishinaabe Bimaadiziwin Research Program   (Canada)

^c PUBLIC HEALTH ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Health equity; Indigenous health; Invasive group A Streptococcus

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CANADA; CELLULITIS; COMORBIDITY; DISEASE SEVERITY; GROUP A STREPTOCOCCAL INFECTION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

EID: 85014179487     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/oid/ofw243     Document Type: Article

References (40)

1. Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13:470-511.
2. Li YA, Martin I, Tsang R, et al. Invasive bacterial diseases in Northern Canada, 2006-2013. Can Commun Dis Rep 2016; 42:74-80.
3. Boyd R, Patel M, Currie BJ, et al. High burden of invasive group a streptococcal disease in the Northern Territory of Australia. Epidemiol Infect 2016; 144:1018-27.
4. Whitehead BD, Smith HV, Nourse C. Invasive group a streptococcal disease in children in Queensland. Epidemiol Infect 2011; 139:623-8.
5. Rudolph K, Bruce MG, Bruden D, et al. Epidemiology of invasive group A streptococcal disease in Alaska, 2001 to 2013. J Clin Microbiol 2016; 54:134-41.
6. Kirlew M, Rea S, Schroeter A, et al. Invasive CA-MRSA in northwestern Ontario: a 2-year prospective study. Can J Rural Med 2014; 19:99-102.
7. Kelly L, Tsang RS, Morgan A, et al. Invasive disease caused by Haemophilus influenzae type A in Northern Ontario First Nations communities. J Med Microbiol 2011; 60(Pt 3):384-90.
8. Ontario Ministry of Health and Long-Term Care. Infectious Diseases Protocol, 2013 Appendix B: Provincial Case Definitions. Group A streptococcal disease, invasive. Available at: http://www.health.gov.on.ca/en/pro/programs/publichealth/oph_standards/docs/gas_cd.pdf. Accessed 22 May 2014.
9. Athey TB, Teatero S, Sieswerda LE, et al. High incidence of invasive group a Streptococcus disease caused by strains of uncommon emm types in Thunder Bay, Ontario, Canada. J Clin Microbiol 2016; 54:83-92.
10. Breiman RF, Davis JP, Facklam RR, et al. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definitions. JAMA 1993; 269:390-91.
11. Beall B, Gherardi G, Lovgren M, et al. emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci. Microbiology 2000; 146:1195-209.
12. Public Health Agency of Canada. Notifiable diseases on-line: invasive group A streptococcal disease. Available at: http://dsol-smed.phac-aspc.gc.ca/dsolsmed/ndis/charts.php?c=pl. Accessed April 21, 2016.
13. Ontario Agency for Health Protection and Promotion (Public Health Ontario). Reportable Disease Trends in Ontario, 2013. Toronto, ON: Queen's Printer for Ontario; 2015.
14. Harris P, Siew DA, Proud M, et al. Bacteraemia caused by beta-haemolytic streptococci in North Queensland: changing trends over a 14-year period. Clin Microbiol Infect 2011; 17:1216-22.
15. Safar A, Lennon D, Stewart J, et al. Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis 2011; 17:983-9.
16. Chansonneuve D. Addictive Behaviours Among Aboriginal People in Canada. Aboriginal Healing Foundation. 2007. Available at: http://www.ahf.ca/downloads/addictive-behaviours.pdf. Accessed 21 April 2016.
17. Gear RJ, Carter JC, Carapetis JR, et al. Changes in the clinical and epidemiological features of group a streptococcal bacteraemia in Australia's Northern Territory. Trop Med Int Health 2015; 20:40-7.
18. Kelly L, Guilfoyle J, Dooley J, et al. Incidence of narcotic abuse during pregnancy in northwestern Ontario: three-year prospective cohort study. Can Fam Physician 2014; 60:e493-8.
19. Gordon J, Dooley J, Balfour-Boehm J, et al. The evolving nature of narcotic use in Northwestern Ontario. Can J Rural Med 2014; 19:158-60.
20. Lamagni TL, Neal S, Keshishian C, et al. Epidemic of severe Streptococcus pyogenes infections in injecting drug users in the UK, 2003-2004. Clin Microbiol Infect 2008; 14:1002-9.
21. Zachariadou L, Stathi A, Tassios PT, et al. Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections. Epidemiol Infect 2014; 142:512-9.
22. Martin J, Murchan S, O'Flanagan D, Fitzpartrick F. Invasive group A streptococcal disease in Ireland, 2004 to 2010. Euro Surveill 2011; 16:pii: 19988.
23. Public Health Agency of Canada. Diabetes in Canada: Facts and Figures from a Public Health Perspective. Ottawa. Available at: http://www.phac-aspc.gc.ca/cd-mc/diabetes-diabete/index-eng.php. Accessed 21 April 2016.
24. Langley G, Hao Y, Pondo T, et al. The impact of obesity and diabetes on the risk of disease and death due to invasive group A Streptococcus infections in adults. Clin Infect Dis 2016; 62:845-52.
25. First Nations Information Governance Centre. First Nations Regional Health Survey (RHS) 2008/10: National report on adults, youth and children living in First Nations communities. Ottawa, ON: FNIGC; Available at: http://fnigc.ca/sites/default/files/First_Nations_Regional_Health_Survey_2008-10_National_Report.pdf. Accessed 1 Apr 2015.
26. Carapetis JR, Walker AM, Hibble M, et al. Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect 1999; 122:59-65.
27. McDonald MI, Towers RJ, Andrews RM, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006; 43:683-9.
28. Marshall CS, Cheng AC, Markey PG, et al. Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg 2011; 85:703-10.
29. Gordon J, Kirlew M, Schreiber Y, et al. Acute rheumatic fever in First Nations communities in northwestern Ontario: Social determinants of health "bite the heart". Can Fam Physician 2015; 61:881-6.
30. Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review of rheumatic heart disease prevalence in children in developing countries: the role of environmental factors. J Paediatr Child Health 2002; 38:229-34.
31. Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011; 30:315-9.
32. Statistics Canada. 2006 Census: Aboriginal Peoples in Canada in 2006: Inuit, Métis and First Nations, 2006 Census: First Nations People. Ottawa, ON: Statistics Canada; Available at: http://www12.statcan.ca/census-recensement/2006/as-sa/97-558/pdf/97-558-XIE2006001.pdf. Accessed 6 February 2017.
33. First Nations Information Governance Centre. First Nations Regional Health Survey (RHS) phase 2 (2008/10) Ontario region final report. Ontario region report on the adult, youth and children living in First Nations communities. Toronto, ON: Chiefs of Ontario; Available at: http://fnigc.ca/sites/default/files/docs/first_nations_regional_health_survey_rhs_phase_2_08-10_ontario_region_final_report_12nov01v8.pdf. Accessed 6 February 2017.
34. Assembly of First Nations. Fact Sheet-First Nations Housing On-Reserve. June 2013 Available at: http://www.afn.ca/uploads/files/housing/factsheet-housing. pdf. Accessed 21 April 2016.
35. Kandel C, Daneman N, Gold W, et al. Invasive Group A Streptococcal Infections in Ontario, Canada: 1992-2013. Poster Abstract: IDWeek 2015. Thursday October 8, 2015 Available at: https://idsa.confex.com/idsa/2015/webprogram/Paper51217.html.
36. British Columbia Centre for Disease Control. Antibiotic Resistance Trends in the Province of British Columbia. 2011. Available at: http://www.bccdc.ca/resource-gallery/Documents/Statistics%20and%20Research/Statistics%20and%20Reports/Epid/AntimicrobialResistanceTrendsinBC_2011.pdf. Accessed 21 April 2016.
37. Steer AC, Law I, Matatolu L, et al. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009; 9:611-6.
38. Bessen DE, Lizano S. Tissue tropisms in group A streptococcal infections. Future Microbiol 2010; 5:623-38.
39. Dale JB, Penfound TA, Chiang EY, Walton WJ. New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci. Vaccine 2011; 29:8175-8.
40. Richardson LJ, Towers RJ, Cheng AC, et al. Diversity of emm sequence types in group A beta-haemolytic streptococci in two remote Northern Territory Indigenous communities: implications for vaccine development. Vaccine 2010; 28:5301-5.